| A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer RS Sandler, S Halabi, JA Baron, S Budinger, E Paskett, R Keresztes, ... New England Journal of Medicine 348 (10), 883-890, 2003 | 1480 | 2003 |
| Randomized, double-blind, phase II study of ruxolitinib or placebo in combination with capecitabine in patients with metastatic pancreatic cancer for whom therapy with … HI Hurwitz, N Uppal, SA Wagner, JC Bendell, JT Beck, SM Wade III, ... Journal of Clinical Oncology 33 (34), 4039, 2015 | 295 | 2015 |
| Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues AE Szafranska, M Doleshal, HS Edmunds, S Gordon, J Luttges, ... Clinical chemistry 54 (10), 1716-1724, 2008 | 278 | 2008 |
| Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy ME Meyerand, JM Pipas, A Mamourian, TD Tosteson, JF Dunn American journal of neuroradiology 20 (1), 117-123, 1999 | 220 | 1999 |
| MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma M Preis, TB Gardner, SR Gordon, JM Pipas, TA Mackenzie, EE Klein, ... Clinical Cancer Research 17 (17), 5812-5821, 2011 | 182 | 2011 |
| Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines JP Mongan, CE Fadul, BF Cole, BI Zaki, AA Suriawinata, GH Ripple, ... Clinical colorectal cancer 8 (2), 100-105, 2009 | 146 | 2009 |
| Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults TB Gardner, LM Glass, KD Smith, GH Ripple, RJ Barth, DA Klibansky, ... Official journal of the American College of Gastroenterology| ACG 108 (10 …, 2013 | 144 | 2013 |
| Phase I study of twice-weekly gemcitabine and concomitant external-beam radiotherapy in patients with adenocarcinoma of the pancreas JM Pipas, SE Mitchell, RJ Barth Jr, R Vera-Gimon, J Rathmann, LP Meyer, ... International Journal of Radiation Oncology* Biology* Physics 50 (5), 1317-1322, 2001 | 100 | 2001 |
| MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm Y Xue, AN Abou Tayoun, KM Abo, JM Pipas, SR Gordon, TB Gardner, ... Cancer genetics 206 (6), 217-221, 2013 | 95 | 2013 |
| Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations X Liu, K Mody, FB De Abreu, JM Pipas, JD Peterson, TL Gallagher, ... Clinical chemistry 60 (7), 1004-1011, 2014 | 91 | 2014 |
| Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation … D Niedzwiecki, MM Bertagnolli, RS Warren, CC Compton, NE Kemeny, ... Journal of clinical oncology 29 (23), 3146-3152, 2011 | 90 | 2011 |
| Effect of neoadjuvant therapy on local recurrence after resection of pancreatic adenocarcinoma SE Greer, JM Pipas, JE Sutton, BI Zaki, M Tsapakos, TA Colacchio, ... Journal of the American College of Surgeons 206 (3), 451-457, 2008 | 86 | 2008 |
| Docetaxel/Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma JM Pipas, RJ Barth, B Zaki, MJ Tsapakos, AA Suriawinata, MA Bettmann, ... Annals of surgical oncology 12, 995-1004, 2005 | 85 | 2005 |
| Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study R Zubarik, SR Gordon, SD Lidofsky, SR Anderson, JM Pipas, G Badger, ... Gastrointestinal endoscopy 74 (1), 87-95, 2011 | 81 | 2011 |
| A randomized double-blind phase 2 study of ruxolitinib (RUX) or placebo (PBO) with capecitabine (CAPE) as second-line therapy in patients (pts) with metastatic pancreatic … H Hurwitz, N Uppal, SA Wagner, JC Bendell, JT Beck, S Wade, ... Journal of Clinical Oncology 32 (15_suppl), 4000-4000, 2014 | 67 | 2014 |
| Gastrointestinal stromal tumor—background, pathology, treatment BL Eisenberg, JM Pipas Hematology/Oncology Clinics 26 (6), 1239-1259, 2012 | 60 | 2012 |
| Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma JM Pipas, BI Zaki, MM McGowan, MJ Tsapakos, GH Ripple, ... Annals of oncology 23 (11), 2820-2827, 2012 | 60 | 2012 |
| Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature EL Zarovnaya, HF Pallatroni, EB Hug, PA Ball, LD Cromwell, JM Pipas, ... Journal of neuro-oncology 84, 49-55, 2007 | 60 | 2007 |
| Bortezomib with or without irinotecan in relapsed or refractory colorectal cancer: results from a randomized phase II study PS Kozuch, CM Rocha-Lima, T Dragovich, H Hochster, BH O'Neil, OT Atiq, ... Journal of clinical oncology 26 (14), 2320-2326, 2008 | 54 | 2008 |
| Dual inhibition of IGF-1R and ErbB3 enhances the activity of gemcitabine and nab-paclitaxel in preclinical models of pancreatic cancer AJ Camblin, EA Pace, S Adams, MD Curley, V Rimkunas, L Nie, G Tan, ... Clinical Cancer Research 24 (12), 2873-2885, 2018 | 53 | 2018 |
